Response to letter to the editor and comment concerning “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”

June 14, 2021

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren’t any new results

Optional text in email:

Additional articles :

Inter Spinal Fixation and Stabilization Device for Lumbar Radiculopathy and Back Pain

Expandable Cages Increase the Risk of Intraoperative Subsidence but Do Not Improve Perioperative Out...

Process Evaluation of Lumbar Interbody Fusion Surgeries in Five Dutch Hospitals: A Qualitative Analy...

Multimodality Intraoperative Neuromonitoring in Lateral Lumbar Interbody Fusion: A Review of Alerts ...

Continuous Rod Load Monitoring to Assess Spinal Fusion Status-Pilot In Vivo Data in Sheep